In Vitro Diagnostic Testing Market - Latest Trends, Competitive Intelligence & Capability Assessment up to 2025

Stratview Research has launched a research report In Vitro Diagnostic Testing Market. The objective of this report is to identify the Trend, Forecast, Competitive Analysis, and Growth Opportunity of Life Science Reagents Market from 2018 to 2025.

This report is segmented in five ways to provide a 360 degree holistic view. The segments are -
• By Product - Instruments, Reagent
• By Technology – Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis, Microbiology
• By Application – Diabetes, Infectious diseases, Oncology, Cardiology, Nephrology, Other Diseases
• By Type of Demand for Sample – Urine, Hair, Oral
• By Testing Facility - Hospital Laboratories, Independent Clinical Laboratories, Drug Rehabilitation Centers, Others
• By Region –
o North America (Country Analysis: the USA, Canada)
o Western Europe (Country Analysis: Germany, France, the UK)
o Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
o Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
o Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others)

This report, from Stratview Research, studies the clinical diagnostics market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Click here to request the detailed TOC of the report: https://www.stratviewresearch.com/toc/415/in-vitro-diagnostic-testing-market.html
OR
Request a sample here: https://www.stratviewresearch.com/Request-Sample/415/in-vitro-diagnostic-testing-market.html

Non-invasive cancer testing is expected to be a hot market in 2019
In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers. In the infectious diseases segment, most of the currently available tests detect a single pathogen, or an antibiotic resistance gene. However, if a patient presents with general symptoms of a respiratory infection, or with symptoms of a gastrointestinal infection or some other type of infection, there are several different pathogens that may have caused the infection. However, syndromic testing is soon becoming a reality where multiple pathogens can be detected, increasing the chances of detection, bringing down the cost of testing and directly impacting the DALY of patients.

Key Players
Over the years, the market has been driven by big names of IVD such as Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) who have been bending the rules of the game. However, in recent years, there are several market disruptors who are openly challenging the monopoly of these players and determined to bring down the cost of care and introduce user friendly and cost effective services and IVD equipment in the market.

Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook

This report studies the global In Vitro Diagnostic Testing Market, keeping in mind the interest of all the stakeholders across the value chain. The rich quality of insights is outcome of -
• Extensive secondary research,
• Rigorous primary interviews with more than 15 industry stakeholders across the value chain.
• Validation and triangulation of data with Stratview Research’s internal database and statistical tools.
• More than 1000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data.

Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html

About Stratview Research
Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

This release was published on openPR.